Keratolytic Winter Erythema clinical trials

Explore recruiting keratolytic winter erythema clinical trials.

Also recruiting in Europe

Keratolytic Winter Erythema trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Treatment of KeratolytTreatment of Keratolytic Winter Erythema with systemic nitroxoline, a phase 2a randomized placebo controlled crossover study of male and female adults from three Norwegian familiesic Winter Erythema with systemic Nitroxoline, a phase 2a randomized placebo controlled cross-over study of male and female adults from three Norwegian families.

Norway

Therapeutic exploratory (Phase II) EU CTIS Study details

Keratolytic Winter Erythema trials by city

Keratolytic Winter Erythema in Toronto Keratolytic Winter Erythema in Vancouver Keratolytic Winter Erythema in Montreal Keratolytic Winter Erythema in Calgary Keratolytic Winter Erythema in Edmonton Keratolytic Winter Erythema in Ottawa Keratolytic Winter Erythema in Winnipeg Keratolytic Winter Erythema in Quebec City Keratolytic Winter Erythema in Hamilton Keratolytic Winter Erythema in Kitchener Keratolytic Winter Erythema in London Keratolytic Winter Erythema in Halifax Keratolytic Winter Erythema in New York Keratolytic Winter Erythema in Los Angeles Keratolytic Winter Erythema in Chicago Keratolytic Winter Erythema in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease